Back to School: How biopharma can reboot drug development. Access exclusive analysis here

LG, Gilead in caspase inhibitor deal

LG Life Sciences (Seoul, South Korea) granted GILD exclusive, worldwide rights, excluding Korea,

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE